Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 28, 2018; 24(4): 511-518
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.511
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.511
Figure 3 Effect of thiopurine on white blood cell count.
A: Absolute number of WBC counts in three groups (Groups A + B vs C vs D) without PSL. We next divided cases into 3 categories: Group A + B, Group C and Group D. Group C was already reported cases with NUDT15 c.415C>T in exon 3 in IBD cases. Group A + B included mutations in exon 1 which is not investigated in IBD. Group A + B and Group C was lower in WBC count and decrease rate than Group D; B: Decrease ratio of WBC counts in three groups (Groups A + B vs C vs D) without PSL; Group A + B and Group C was lower in WBC count and decrease rate than Group D; Group A + B and Group C was lower in decrease rate than Group D. PSL: Prednisolone; WBC: White blood cell; IBD: Inflammatory bowel disease.
- Citation: Kojima Y, Hirotsu Y, Omata W, Sugimori M, Takaoka S, Ashizawa H, Nakagomi K, Yoshimura D, Hosoda K, Suzuki Y, Mochizuki H, Omata M. Influence of NUDT15 variants on hematological pictures of patients with inflammatory bowel disease treated with thiopurines. World J Gastroenterol 2018; 24(4): 511-518
- URL: https://www.wjgnet.com/1007-9327/full/v24/i4/511.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i4.511